WQ1 Stock Overview
Develops solutions to support diagnostic imaging and digital medicine in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
MedApp S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.032 |
| 52 Week High | zł0.079 |
| 52 Week Low | zł0.031 |
| Beta | 0.86 |
| 11 Month Change | -6.47% |
| 3 Month Change | -25.00% |
| 1 Year Change | -55.71% |
| 33 Year Change | -84.56% |
| 5 Year Change | n/a |
| Change since IPO | -84.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| WQ1 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 1.9% | -0.6% | -1.3% |
| 1Y | -55.7% | -33.0% | 7.4% |
Return vs Industry: WQ1 underperformed the German Healthcare Services industry which returned -33.1% over the past year.
Return vs Market: WQ1 underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| WQ1 volatility | |
|---|---|
| WQ1 Average Weekly Movement | 5.5% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: WQ1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: WQ1's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 22 | David Odrakiewicz | medapp.pl |
MedApp S.A. develops solutions to support diagnostic imaging and digital medicine in Poland. The company offers CarnaLife System, an analytical telemedicine system that enables physician to assess and monitor the health of patients and conduct consultations, as well as enable remote measurement, such as pulse oximeter, electrocardiograph, blood pressure monitor, thermometer, scale, auscultation device, and others. It also offers CarnaLife Holo, a 3D imaging system for 3D visualization imaged medical data, which supports the planning and performance of medical procedures; Digital Clinic that offers remote medical care, medical consultations, diagnostics, and in-depth health monitoring; and HoloComm for remote product demonstration in 3D.
MedApp S.A. Fundamentals Summary
| WQ1 fundamental statistics | |
|---|---|
| Market cap | €10.48m |
| Earnings (TTM) | -€946.68k |
| Revenue (TTM) | €1.23m |
8.5x
P/S Ratio-11.1x
P/E RatioIs WQ1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WQ1 income statement (TTM) | |
|---|---|
| Revenue | zł5.33m |
| Cost of Revenue | zł1.05m |
| Gross Profit | zł4.28m |
| Other Expenses | zł8.39m |
| Earnings | -zł4.11m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.016 |
| Gross Margin | 80.27% |
| Net Profit Margin | -77.14% |
| Debt/Equity Ratio | 7.4% |
How did WQ1 perform over the long term?
See historical performance and comparison